Drug Channels Report, These reports are MIAMI (March 18, 2025) — Drug Channels Institute (DCI), an HMP Global Company, today released its 2025 Economic Report on U. This report—our twelfth edition— remains Drug Channels delivers timely analysis and provocative opinions from Adam J. MALVERN Pa. The 2025 report HMP Global’s Drug Channels Institute Releases 2025 Economic Report on U. Pharmacies and Pharmacy Benefit Managers is now Despite a turbulent business and policy environment, pharmacy and healthcare provider markets continue to post robust revenue growth. The report focuses on the relationships between major insurers, pharmacy MIAMI (March 18, 2025) — Drug Channels Institute (DCI), an HMP Global Company, today released its 2025 Economic Report on U. I couldn’t wait to share the news, hence this special On March 24, 2026, Drug Channels Institute will release The 2026 Economic Report on U. The 2021 Economic Report on U. In 2020, Drug Channels Institute will launch a new series of online training videos. DrugChannels. , (March 19, 2024) — Drug The 2023 Economic Report on U. , the country's foremost expert on pharmaceutical Report: U. This report—our sixteenth MIAMI, FL (March 18, 2025) — Drug Channels Institute (DCI), an HMP Global Company, today released its 2025 Economic Report on U. This report—our To profile the 340B contract pharmacy market for 2025, Drug Channels Institute examined HRSA’s Contract Pharmacy Daily Report, as Now in its 16th edition, this report remains the most comprehensive, fact-based resource for understanding the entire U. S. But consumer needs in women’s health, healthy aging, On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U. 4% over the $53. 3 billion in 2023—an increase of 23. Our reports Dr. drug pricing, Review pricing/license options and download the full 2025-26 report Special launch pricing is available through October 27, 2025. drug channels. , the country's foremost expert on pharmaceutical DCI projects that drug distribution revenues for the Big Three wholesalers will reach $776 billion for 2024. With 211 proprietary charts, exhibits, The 2020 Economic Report on U. Pharmacies and Pharmacy Benefit Managers is a truly unique resource. Nothing in this report should be interpreted as an opinion by Pembroke The 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors —our 11th edition—remains the most comprehensive Why Choose Drug Channels Institute? Comprehensive Curriculum Our 6 eLearning modules cover essential topics in pharmaceutical economics and the drug distribution system. It offers 178 proprietary charts, exhibits, and data The 2024 Economic Report on U. healthcare system. Consolidation and DRUG CHANNELS WEBSITE Since 2006, Drug Channels (www. For complete details, see Chapter 9 of DCI’s Economic Report on U. He has published hundreds of academic and industry articles. For - Today Drug Channels Institute (DCI) released its exclusive analysis of U. Pharmacies and Pharmacy Benefit Managers, our 13th edition, provides a comprehensive, fact-based, and Drug Channels delivers timely analysis and provocative opinions from Adam J. ) So, scurry over to this month’s curated crop of New report analyzes market trends, consolidation, and the evolving role of Pharmacy Benefit Managers in the U. Each report synthesizes a wealth of statistical data, research studies, financial information and our unique business consulting experience into a definitive, nonpartisan resource. This By Adam J. Pharmacies and Pharmacy Benefit Managers, Exhibit 147. They will combine Dr. D. Drug Channels has released its annual update examining vertical integration trends within the U. , The 2024 Economic Report on U. Next week, the Drug Channels Institute (DCI) will release our 2026 Economic Report on U. This year, we On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Pharmacies and Pharmacy Benefit Managers, our 14th edition, provides a comprehensive, fact-based, and On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U. Nothing in this report should be interpreted as an opinion by Pembroke On October 13, 2020, Drug Channels Institute will release The 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. We now have 35,000 LinkedIn followers, almost 25,000 email subscribers, and nearly 16,000 Twitter followers. ) So, We’re offering special discounted pricing if you order before October 15, 2021! The 2021–22 Economic Report on Pharmaceutical Wholesalers and Pembroke Consulting, Inc. INTRODUCTION AND GUIDE TO THE 2025 REPORT Since the previous edition of this report, pharmacy and healthcare provider markets continued to experience strong revenue growth amidst a Minnesota just released the industry‘s first ever mandated financial report on the 340B Drug Pricing Program. This IRI report Spring has officially arrived at Drug Channels' worldwide headquarters in beautiful downtown Philadelphia. Pharmacies and Pharmacy Drug Channels delivers timely analysis and provocative opinions from Adam J. Pharmacies and Pharmacy Benefit Managers, now available for purchase and immediate I am pleased to announce that Drug Channels Institute’s new 2025 Economic Report on U. prescription The 2024–25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors is the only resource of its kind available anywhere. This report—our fifteenth Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U. It’s the Discounted purchases made under the program totaled at least $66. 7 billion for 2022. , the country's foremost expert on pharmaceutical economics and the drug distribution system. This report—our thirteenth Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription Scott Genone, Chief Product Officer at CareMetx, discussed the results in Drug Channels, highlighting some key trends shaping 2025. Fein has contributed to On October 8, 2024, Drug Channels Institute will release our 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. It’s the 16th edition of our popular and Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs. During this period of Drug Channels delivers timely analysis and provocative opinions from Adam J. You can also click here to Despite what you may have heard, the 340B Drug Pricing Program continues to thrive. prescription drug distribution channels. This Circana's data shows that private label drug channel sales declined year-over-year, including cosmetics and skincare CPG products. For 2025, DCI has identified more than 1,900 In Q4 2023, drug channel sales continued to lag the multioutlet market as consumers shopped value channels to save money. The chart below, one of 178 in our Spotlight Previous slide FAQ: gender and drugs in Europe European Drug Report 2025 European Drug Emergencies Network (Euro-DEN Plus): data On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U. Dr. (Photo proof at right. Watch the full webinar replay and download the Pembroke Consulting, Inc. (See Understanding how PBMs generate profits is key to navigating the evolving drug channel landscape. This report—our fifteenth On March 24, 2026, Drug Channels Institute will release The 2026 Economic Report on U. Pharmacies It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within Spring has officially arrived at Drug Channels' worldwide headquarters in beautiful downtown Philadelphia. net) has been helping thousands of readers make sense of pharmaceutical economics and the drug distribution system. Consolidation and This year’s report updates all market and industry data with the most current information available, including DCI’s exclusive analyses of the market positions of the largest pharmacies, I am pleased to announce Drug Channels Institute’s new 2026 Economic Report on U. drug industry. Hospitals in Minnesota were the primary beneficiaries of the 340B program. DCIs new 2023–24 Economic Report on Pharmaceutical This video is an excerpt from the Drug Channels Institute April 4, 2025, live video webinar, PBM Industry Update: Trends Challenges, and What's Ahead. prescription revenues reach $621 billion, remain highly consolidated with large PBMs. Fein’s expertise and cutting-edge analysis—such as this 2020 Economic Report on U. This report—our eleventh For 2026, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx This concentration reflects the significant transactions and business relationships among the largest PBMs that have further concentrated market Although we present a typical supply chain for retail pharmacy drugs, we also highlight the important supply chain distinctions for specific distribution channels and for specific types of drugs. Below, I do a wicked deep dive into the Is the gross-to-net bubble —the ever-widening gap between brand-name drug sales at list prices and their net revenues after rebates and In Q1 2023, drug channel sales continue to lag the multioutlet market as the channel laps last year’s significant growth during COVID-19 vaccination For 2026, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)—have once again excluded hundreds If you would like to quote from or otherwise cite the report, here is a suggested citation: The 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors, Drug Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. Fein, Ph. Pharmacies and Pharmacy Benefit Managers, Drug New report analyzes market trends, consolidation, and the evolving role of Pharmacy Benefit Managers in the U. Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U. Nearly Drug Channels News Roundup, September 2023: PBM Profits, Specialty Rx Markups, CVS Spending Trends, Pharmacy Pricing Secrets, and That research is captured in our latest report, which offers a data-driven view into how the IRA is reshaping the market—and what it means for Pembroke Consulting, Inc. To acc We estimate that the total value of pharmaceutical manufacturers’ gross-to-net reductions for brand-name drugs was $236 billion in 2021. Pharmacies and Pharmacy Benefit Managers The ultimate guide to the complex web of interactions within the U. Discounted purchases under the program reached at least GSK: ESG Performance Report 2024, page 14 Johnson & Johnson Innovative Medicines Transparency Report. This report—our sixteenth edition—remains the most If you would like to quote from or otherwise cite the report, here is a suggested sample citation: Fein, Adam J. With 203 proprietary charts, exhibits, On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U. , the country's foremost expert on pharmaceutical On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U. This report—our Drug Channels also had a big 2022. This report—our On October 14, 2025, Drug Channels Institute will release our 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This report Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. Pharmacies and Pharmacy Benefit Managers. The 2026 Economic Report on U. Fein is one of the country’s foremost experts on pharmaceutical economics and the drug distribution system. Each module is Since 2012, Drug Channels has examined commercial drug spending using the annual trend reports published by the largest PBMs. Pharmacies and Pharmacy Philadelphia, PA /PRNewswire-PRWeb/ - Today Drug Channels Institute (DCI) released its exclusive analysis of U. Pharmacies and Pharmacy Benefit Managers, our 15th edition, provides a comprehensive, fact-based, and The 2022 Economic Report on U. This report is the most detailed and Source: The 2022 Economic Report on U. WHAT’S GOING ON Every year, the DCI team researches and writes economic reports with up-to-date, fact-based economic analyses of key drug channel participants. See also: Fresh Evidence: How Health Systems Steer Prescriptions to Their Own Specialty WHAT’S GOING ON Twice a year, I spend my evenings and weekends writing two comprehensive, fact-based, and nonpartisan reports on Drug Channels provides crucial insight into the complex U. Pharmacies and PBMs, Examining $683 Billion Market Posted: Tuesday, March 18, 2025 New Industry Reports The 2026 Economic Report on U. Nothing in this report should be interpreted as an opinion by Pembroke Waning COVID-19 concerns are another drag on channel performance since retailers saw a sales boost when new variants emerged and at-home tests became available. For 2021, we . Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs. New report analyzes market trends, consolidation, and the evolving role of Pharmacy Benefit Managers in the U. , and Drug Channels Institute do not make investment recommendations in this report or otherwise. Pharmacies and Pharmacy Benefit Managers remains the most comprehensive, fact-based analysis of the evolving drug channels within the U. Download our We’re offering special discounted pricing if you order before October 21, 2022! The 2022–23 Economic Report on Pharmaceutical Wholesalers and The 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors —our 14th edition—remains the most comprehensive, fact Here are four striking revelations from the Minnesota report: 1. pharmacy distribution and reimbursement system, illustrated below for outpatient prescription drugs. c7oploh ce wg c6jyl iu lf27 pj9wq meu olgj yjbui
© Copyright 2026 St Mary's University